Mycobacterium Tuberculosis Second Line Drug (MTB 2ND Line Drugs)

Discover the latest on Medi Linx Laboratory

KNOW OUR DIRECTORY OF SERVICES

Explore our comprehensive test menu covering a wide range of medical specialties to support accurate diagnoses and patient management. From routine chemistry to advanced genomics—we’ve got you covered.

Mycobacterium Tuberculosis Second Line Drug (MTB 2ND Line Drugs)

Test Information:
This test refers to drug susceptibility testing for second line drug for tuberculosis. It provides improve treatment outcomes and management for patients with resistance to primary TB drug. This test is culture-based susceptibility test that uses MGIT media with the aid of BACTEC MGIT 960 system.

Specimen Container:
Lowenstein-Jensen (LJ) Medium

Specimen Type:
MDR TB on MGIT or LJ. 2 day old isolate on MGIT.

Required Volume:
7 mL MGIT with confluent growth

Patient Preparation:|
No Patient Preparation

Notes:
Result of Culture and Sensitivity for first line drug of the isolate for testing must be included.

Storage & Stability
(Before Processing)

  • Storage: Incubator (35 to 37°C)
    Stability: 2 days

Transport Temperature:
Ref (18°C to 24°C)

Test Category:
Routine

Test Schedule:
Monday to Friday

Results Availability:
After 3 to 4 weeks

At MEDI LINX LABORATORY INC., we are committed to safeguarding the privacy and security of your personal and health-related information. This data privacy statement outlines how we collect, use, disclose, and protect your data to ensure compliance with applicable laws and regulations, including but not limited to Republic Act No. 10173, its Implementing Rules and Regulations, and the issuance/s set forth by the National Privacy Commission (NPC).

Click here to read the Data Privacy Statement in full.